Frequent co-occurrence of the TATA box mutation associated with Gilbert’s syndrome (UGT1A1*28) with other polymorphisms of the UDP-glucuronosyltransferase-1 locus (UGT1A6*2 and UGT1A7*3) in Caucasians and Egyptians-Reference-Cited by-同舟云学术

Frequent co-occurrence of the TATA box mutation associated with Gilbert’s syndrome (UGT1A1*28) with other polymorphisms of the UDP-glucuronosyltransferase-1 locus (UGT1A6*2 and UGT1A7*3) in Caucasians and Egyptians

Published:2003-05 Issue:9 Volume:65 Page:1521-1527
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Köhle Christoph,Möhrle Bernd,Münzel Peter A.,Schwab Matthias,Wernet Dorothee,Badary Osama A.,Bock Karl Walter

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference27 articles.

1. Genetic epidemiology of environmental toxicity and cancer susceptibility: human allelic polymorphisms in drug metabolizing enzyme genes, their functional importance, and nomenclature issues;Nebert;Drug Metab. Rev.,1999

2. The genetic basis of the reduced expression of bilirubin UDP glucuronosyltransferase 1 in Gilbert’s syndrome;Bosma;N. Engl. J. Med.,1995

3. Genetic variation in bilirubin UPD glucuronosyltransferase gene promoter and Gilbert’s syndrome;Monaghan;Lancet,1996

4. Association of human liver bilirubin UDP-glucuronyltransferase activity with a polymorphism in the promoter region of the UGT1A1 gene;Raijmakers;J. Hepatol.,2000

5. UGT1A1 genotypes and glucuronidation of SN 38 the active metabolite of irinotecan;Ando;Ann. Oncol.,1998

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gilbert Syndrome;International Journal of Nursing Education and Research;2021-07-01

2. Evaluation of the Safety of Direct-Acting Antiviral Agentsin Patients with Chronic HCV-Infection and with UGT1A1*28 Polymorphism;Клиническая инфектология и паразитология;2020-10-15

3. Effect of Mutations on mRNA and Globin Stability: The Cases of Hb Bernalda/Groene Hart and Hb Southern Italy;Genes;2020-07-31

4. The Evaluation of the Efficacy and Safety of Patients with Chronic Hepatitis C and Cirrhosis with Polymorphism UGT1A1*28 Treatment with Direct Antiviral Drugs and Ribavirin;Рецепт;2020-07-21

5. The efficacy and safety of direct-acting antiviral agents in patients with chronic HCV infection and UGT1A1*28 polymorphism;Clinical Microbiology and Antimicrobial Chemotherapy;2020